EGR1 was shown to be overexpressed in prostate cancer and to be involved in the regulation of different steps involved in the initiation and progression of prostate cancer, including mitogenesis, invasiveness, angiogenesis, and metastasis (Svaren et al, 2000). The gene discussed is EGR1; the disease is prostate carcinoma.